Welcome
Welcome to our official website
|
Who are we?
SafeTestsForLife (STL) is a French and strictly non profit association recognised as being of general interest. It promotes the development and validation of innovative non invasive tests (with a simple blood test) in the fields of prenatal diagnosis (PND) of genetic diseases and early diagnosis of solid cancers.
SafeTestsForLife, located in the heart of Paris, enjoys a privileged environment and the close collaboration with top scientific, clinical and industrial partners.
SafeTestsForLife works in partnership with INSERM research teams, specialised in the fields of non invasive prenatal diagnosis and predictive oncology.
SafeTestsForLife finances the development and validation of non invasive diagnostic tests with a major impact on public health. These research programs are validated by a scientific committee composed of high ranking personalities in French and international research.
SafeTestsForLife gathers the donations and subsidies necessary to finance its priority research projects:
- Non Invasive Prenatal Diagnosis of Trisomy 21
- Early diagnosis of solid cancers
Donations are managed in partnership with INSERM. Donations to STL entitle donors to an income tax reduction of 66 % of the amount of the donation.
Your help is needed!
Project 1 : A validated and safe prenatal diagnosis of Trisomy 21, performed on a blood sample and as reliable as the invasive method amniocentesis, is now expected in the near future! This means the end of a nightmare for pregnant women!
Project 2 : Many lives can be saved if invasive cancer is diagnosed at an early stage! And this through a simple blood test!
This research suffers a cruel lack of funding! We encourage you to help research even with a small donation! Please disseminate the address of this site and ask others to join us and help this effort! Contribute to a great clinical advance aimed at saving lives!
Please contact us for more information on the subject.
Major publications on the process used for these tests.
|